GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Series GSE153118 Query DataSets for GSE153118
Status Public on Sep 15, 2020
Title Experimental Autoimmune Encephalomyelitis is Associated with Changes of the Microbiota Composition in the Gastrointestinal Tract
Organisms Mus musculus; blank sample
Experiment type Other
Summary The gut microbiome is known to be sensitive to changes in the immune system, especially during autoimmune diseases such as Multiple Sclerosis (MS). Our study examines the changes to the gut microbiome that occur during Experimental Autoimmune Encephalomyelitis (EAE), an animal model for MS. We collected fecal samples at key stages of EAE progression and quantified microbial abundances with 16S V4 amplicon sequencing. Our analysis of the data suggests that commensal Lactobacillaceae fall in abundance during EAE while other commensal populations belonging to the Clostridiaceae, Ruminococcaceae, and Peptostreptococcaceae families expand. Community analysis with microbial co-occurrence networks points to these three taxa as mediators of gut microbiome dysbiosis. We also employed PICRUSt2 to impute MetaCyc Enzyme Consortium (EC) pathway abundances from the original microbial abundance data. From this analysis, we found that a number of imputed EC pathways responsible for the production of compounds with indole groups are enriched in mice undergoing EAE. Our analysis and interpretation of results provides a detailed picture of the changes to the gut microbiome that are occurring throughout the course of EAE disease progression.
Overall design Three-group experimental autoimmune encephalomyelitis (EAE) study in which one group was left naïve, one was immnuized with Complete Freund's Adjuvant (CFA), and one was immunized with an emulsion of MOG (myelin oligodendrocyte protein) and CFA to induce EAE. Fecal samples were taken at 2 days before immunizations and at 8, 14, 19, and 29 days afterwards during the progression of EAE. Fecal samples were processed for 16S amplicon sequencing to identify and quantify microbes and their abundances over time and accross immunization treatments.

Sequencing performed at UVa Genome Analysis & Technology Core,
Office of Research Core Administration.
University of Virginia Health System,
P.O. Box 800741,
Charlottesville, VA 22908-0741
Web link
Contributor(s) Johanson II DM, Gaultier A, Marin I, Goertz J
Citation(s) 32938979
Submission date Jun 23, 2020
Last update date Oct 02, 2020
Contact name David Michael Johanson
Phone 3307327182
Organization name UVa School of Medicine
Department Department of Neuroscience
Lab UVa Neuroscience Bioinformatics
Street address 200 Jeanette Lancaster Way
City Charlottesville
State/province VA
ZIP/Postal code 22903
Country USA
Platforms (2)
GPL16417 Illumina MiSeq (Mus musculus)
GPL27039 Illumina MiSeq (blank sample)
Samples (91)
GSM4634463 543CFA-2
GSM4634464 543CFA14
GSM4634465 543CFA19
BioProject PRJNA641454
SRA SRP268533

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE153118_ASV_abundances.csv.gz 103.5 Kb (ftp)(http) CSV
GSE153118_ASV_taxonomy.csv.gz 74.8 Kb (ftp)(http) CSV
GSE153118_Sample_Data.csv.gz 1.1 Kb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap